Abstract
Galodif (1-((3-chlorophenyl)(phenyl)methyl)urea) is an anticonvulsant that can also be used in the treatment of alcohol addiction. However, galodif is practically insoluble in water, which significantly limits its use for therapeutic purposes. It is known that good water solubility improves the bioavailability of pharmaceuticals, which ensures a reduction in the applied dose and a decrease in possible side and undesirable effects of the drug. In this paper, a method of solubilization of galodif in water using a self-emulsifying drug delivery system (SEDDS) is proposed. The developed pharmacological compositions consist of ingredients that are available and widely used in pharmacy. The use of gelatin capsules with developed SEDDS increases the solubility of galodif in water more than 80% compared to its tablet form. An increase in the dissolution rate of the drug with SEDDS in the intestinal environment has been shown.
Similar content being viewed by others
DATA AVAILABILITY
The data that support the findings of this study are available from the corresponding author upon reasonable request.
REFERENCES
Ghosh, A.K. and Brindisi, M., J. Med. Chem., 2020, vol. 63, pp. 2751−2788. https://doi.org/10.1021/acs.jmedchem.9b01541
Filimonov, V.D., Bakibaev, A.A., Pustovoitov, A.V., Tignibidina, L.G., Pechenkin, A.G., Gorshkova, V.K., and Saratikov, A.S., Pharm. Chem. J., 1988, vol. 22, pp. 358–363. https://doi.org/10.1007/BF00769646
Shushpanova, T.V., Bokhan, N.A., Stankevich, K.S., Novozheeva, T.P., Mandel, A.I., Schastnyi, E.D., Kisel, N.I., Shushpanova, O.V., Udut, V.V., Safronov, S.M., Boev, R.S., and Knyazeva, E.M., Pharm. Chem. J., 2021, vol. 54, pp. 1093–1100. https://doi.org/10.1007/s11094-021-02327-x
Shushpanova, T.V., Bokhan, N.A., Lebedeva, V.F., Mandel, A.N., Solonskii, A.V., Schastnyy, A.D., Semke, A.V., Kasennich, T.V., Udut, V.V., Arbit, G.A., and Filimonov, V.D., J. Addict. Res. Ther., 2016, vol. 7, pp. 271–276. https://doi.org/10.4172/2155-6105.1000271
Shushpanova, T.V. and Solonskii, A.V., Neurosci. Behav. Physiol., 2013, vol. 43, pp. 423–430. https://doi.org/10.1007/s11055-013-9749-5
Shushpanova, T.V., Mandel', A.I., Bokhan, N.A., Badyrgy, I.O., Novozheyeva, T.P., Schastnyy, E.D., Solonskiy, A.V., Grushchenko, N.F., Udut, V.V., Shushpanova, O.V., Markova, E.V., and Knyazeva, E.M., Yakut. Med. Zhurn., 2019, pp. 109–112. https://doi.org/10.25789/YMJ.2019.68.32
Kuksenok, V.Yu., Shtrykova, V.V., Filimonov, V.D., Druganov, A.G., Bondarev, A.A., and Stankevich, K.S., Chirality, 2018, vol. 30, pp. 1135–1143. https://doi.org/10.1002/chir.23005
Boyd, B.J., Bergström, C.A.S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., Müllertz, A., Bauer-Brandl, A., and Jannin, V., Eur. J. Pharm. Sci., 2019, vol. 137, pp. 1–27. https://doi.org/10.1016/j.ejps.2019.104967
Jambhekar, S.S. and Breen, P., Drug Discov. Today, 2016, vol. 21, pp. 363–368. https://doi.org/10.1016/j.drudis.2015.11.016
Negrya, S.D., Jasko, M.V., Solyev, P.N., Karpenko, I.L., Efremenkova, O.V., Vasilyeva, B.F., Sumarukova, I.G., Kochetkov, S.N., and Alexandrova, L.A., J. Antibiot. (Tokyo), 2020, vol. 73, pp. 236–246. https://doi.org/10.1038/s41429-019-0273-x
Abuzara, S.M., Hyuna, S.-M., Kima, J.-H., Parka, H.J., Kimc, M.-S., Parkd, J.-S., and Hwang, S.-J., Int. J. Pharm., 2018, vol. 538, pp. 1–13. https://doi.org/10.1016/j.ijpharm.2017.12.041
Silva, F.L.O.D., Marques, M.B.D.F., Kato, K.C., and Carneiro, G., Exp. Opin. Drug Dis., 2020, vol. 15, pp. 853–864. https://doi.org/10.1080/17460441.2020.1750591
Sripriyalakshmi, S., Jose, P., Ravindran, A., and Anjali, C.H., Cell Biochem. Biophys., 2014, vol. 70, pp. 17–26. https://doi.org/10.1007/s12013-014-9896-5
Kim, S., Shi, Y., Kim, J.Y., Park, K., and Cheng, J.-X., Exp. Opin. Drug Del., 2010, vol. 7, pp. 49–62. https://doi.org/10.1517/17425240903380446
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., and Leroux, J.-C., Eur. J. Pharm. Biopharm., 2010, vol. 76, pp. 147–158. https://doi.org/10.1016/j.ejpb.2010.06.007
Qiao, N., Li, M., Schlindwein, W., Malek, N., Davies, A., and Trappitt, G., Int. J. Pharm., 2011, vol. 419, pp. 1–11. https://doi.org/10.1016/j.ijpharm.2011.07.037
Alekseyev, K.V., Turchinskaya, K.G., Blynskaya, E.V., and Tikhonova, N.V., Vestn. Nov. Med. Tekhnol., 2014, vol. 21, pp. 128–133.
Kohli, K., Chopra, S., Dhar, D., Arora, S., and Khar, R.K., Drug Discov. Today, 2010, vol. 15, pp. 958–965. https://doi.org/10.1016/j.drudis.2010.08.007
Park, H., Ha, E.-S., and Kim, M.-S., Pharmaceutics, 2020, vol. 12, pp. 1–57. https://doi.org/10.3390/pharmaceutics12040365
Seilerova, L., Sieberova, V., Kratochvil, B., and Vetchy, D., Chemicke Listy, 2014, vol. 108, pp. 956–960.
AboulFotouh, K., Allam, A.A., El-Badry, M., and El-Sayed, A.M., Colloids Surf. B Biointerfaces, 2018, vol. 167, pp. 82–92. https://doi.org/10.1016/j.colsurfb.2018.03.034
Chatterjee, B., Almurisi, S.H., Dukhan, A.A.M., Mandal, U.K., and Sengupta, P., Drug Del., 2016, vol. 23, pp. 3639–3652. https://doi.org/10.1080/10717544.2016.1214990
Sladkova, V., Kratochvil, B., and Dorozko, E., Chemicke Listy, 2014, vol. 108, pp. 1018–1102.
Gumaste, S.G., Freire, B.O.S., and Serajuddin, A.T.M., Eur. J. Pharm. Sci., 2017, vol. 110, pp. 124–133. https://doi.org/10.1016/j.ejps.2017.02.022
Chavan, R.B., Modi, S.R., and Bansal, A.K., Int. J. Pharm., 2015, vol. 495, pp. 374–384. https://doi.org/10.1016/j.ijpharm.2015.09.011
Mondal, S., Islam, T., Rahman, M.S., and Islam, A., J. Appl. Pharm. Sci., 2013, vol. 3, pp. 64–67. https://doi.org/10.7324/JAPS.2013.3712
Menzel, C., Holzeisen, T., Laffleur, F., Zaichik, S., Abdulkarim, M., Gumbleton, M., and BernkopSchnürch, A., J. Control. Release, 2018, vol. 277, pp. 165–172. https://doi.org/10.1016/j.jconrel.2018.03.018
Pires, P.C., Peixoto, D., Teixeira, I., Rodrigues, M., Alves, G., and Santos, A.O., Eur. J. Pharm. Sci., 2020, vol. 141, Article ID: 105099. https://doi.org/10.1016/j.ejps.2019.105099
Shtrykova, V.V., Kuksenok, V.U., and Filimonov, V.V., Patent RU2614142C1.
Funding
This work was done within the framework of the state assignment of the Ministry of science and higher education of the Russian Federation (Science no. FSWW-2023-0008).
Author information
Authors and Affiliations
Contributions
All authors participated in writing the text of the article and made an equal contribution.
Corresponding author
Ethics declarations
This article does not contain any studies involving patients or animals as test objects. Informed consent was not required for this article. No conflict of interest was declared by the authors.
Additional information
Publisher's Note. Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kuksenok, V.U., Shtrykova, V.V., Filimonov, V.D. et al. Innovative Technology of the Self-Emulsifying Drug Delivery System of the Anticonvulsant Galodif. Russ J Bioorg Chem 49 (Suppl 1), S8–S12 (2023). https://doi.org/10.1134/S1068162023080022
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162023080022